Antiphospholipid syndrome: from the laboratory bench to the patients' bedside.

about

Beta2GP-I in the anti phospholipid (Hughes') syndrome--from a cofactor to an autoantigen--from induction to prevention of antiphospholipid syndrome.

P2860

Q54483428-36EC21CF-9785-419F-9BA9-970ABA7D1595

P2860

Antiphospholipid syndrome: from the laboratory bench to the patients' bedside.

Item

http://www.wikidata.org/entity/Q40529769

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

1995年论文

@zh

1995年论文

@zh-cn

name

Antiphospholipid syndrome: from the laboratory bench to the patients' bedside.

@en

type

Item

label

Antiphospholipid syndrome: from the laboratory bench to the patients' bedside.

@en

prefLabel

Antiphospholipid syndrome: from the laboratory bench to the patients' bedside.

@en

P1476

Antiphospholipid syndrome: from the laboratory bench to the patients' bedside.

@en

P2860

Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype.

Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies.

Antiphospholipid antibody syndrome: immunologic and clinical aspects.

Fetal loss treatment in patients with antiphospholipid antibodies.

Effect of long-acting thromboxane receptor antagonist (BMS 180,291) on experimental antiphospholipid syndrome.

Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice.

The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrome.

The effect of intravenous gamma-globulin on the induction of experimental antiphospholipid syndrome.

Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3

P304

S33-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1177/096120339400400108

http://www.w3.org/2001/XMLSchema#string

P478

4 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Yehuda Shoenfeld

Miri Blank

Pnina Fishman

P577

1995-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7757109

http://www.w3.org/2001/XMLSchema#string

Antiphospholipid syndrome: from the laboratory bench to the patients' bedside.

about

P2860

P2860

Antiphospholipid syndrome: from the laboratory bench to the patients' bedside.

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P478

P50

P577

P698

P356

P1433

P1476

P2860

P304

P31

P356

P478

P50

P577

P698